ICIs-Related Cardiotoxicity in Different Types of Cancer

Immune checkpoint inhibitors (ICIs) are rapidly developing immunotherapy cancer drugs that have prolonged patient survival. However, ICIs-related cardiotoxicity has been recognized as a rare, but fatal, consequence. Although there has been extensive research based on different types of ICIs, these s...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Mei, Yu, Ting, Zhang, Zhenzhen, Zhang, Jing, Wang, Rujian, Tse, Gary, Liu, Tong, Zhong, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324462/
https://www.ncbi.nlm.nih.gov/pubmed/35877565
http://dx.doi.org/10.3390/jcdd9070203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324462/
https://www.ncbi.nlm.nih.gov/pubmed/35877565
http://dx.doi.org/10.3390/jcdd9070203

Ejemplares similares